{"id":62975,"date":"2026-04-21T04:02:27","date_gmt":"2026-04-21T02:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/"},"modified":"2026-04-21T04:02:27","modified_gmt":"2026-04-21T02:02:27","slug":"osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/","title":{"rendered":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season"},"content":{"rendered":"
\n

MISSOULA, Mont.–(BUSINESS WIRE)–#BarebackRiding<\/a>–OSRX, Inc., an FDA-registered outsourcing facility specializing in compounded ophthalmic medications, today announced a partnership with professional rodeo athlete and Montana native Sam Petersen\u2014the 2025 world No. 2 bareback rider and Wrangler National Finals Rodeo average champion. The collaboration advances the company\u2019s Ride with OSRX campaign\u2014an initiative celebrating rising American talent forged through discipline, resilience, and a relentless pursuit of excellence.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nBoth Petersen and OSRX share roots in Montana\u2014and a competitive mindset built on performance. Known for his grit in and out of the arena, Petersen competes with consistency, control, and the ability to execute under extreme pressure. OSRX applies those same standards to compounded ophthalmic medications, where precision and reliability directly impact patient outcomes. That focus has fueled the company\u2019s rapid growth from a Missoula startup into one of the nation\u2019s largest ophthalmic compounders, now trusted by more than 10,000 prescribers nationwide.<\/p>\n

\n\u201cMontana breeds a certain type of person\u2014and company,\u201d said Eric Garner, Chief Commercial Officer at OSRX. \u201cWhen you watch Sam ride, you see someone who demands more of himself every single time out. That attitude is exactly how OSRX was built\u2014by doing things the right way, earning trust, and delivering consistently when it matters most. As we continue to grow nationally, partnering with Sam is a natural extension of who we are and where we\u2019re going.\u201d<\/p>\n

\nPetersen echoed the connection between their disciplines. \u201cThere\u2019s a lot of overlap in how we think about what we do,\u201d Petersen said. \u201cFor me, it\u2019s about putting in the work and performing at the highest level every time I nod my head. You can tell OSRX takes pride in getting the details right and producing great medications.\u201d<\/p>\n

\nFounded in 2019, OSRX formulates compounded ophthalmic medications designed to simplify post-surgical care and support ongoing treatment for conditions such as glaucoma. By streamlining dosing and prioritizing affordable pricing regardless of insurance status, the company is working to expand access to quality, affordable eye care for everyday Americans.<\/p>\n

\n\u201cAt the end of the day, performance matters\u2014whether it\u2019s in rodeo or medicine,\u201d Garner added. \u201cWe believe patients and providers shouldn\u2019t have to choose between quality care and affordability. That\u2019s what we\u2019re creating, and that\u2019s what Ride with OSRX represents.\u201d<\/p>\n

\nPetersen becomes the latest athlete supported through Ride with OSRX, joining a growing roster of next-generation competitors across high-performance sports, including racing phenom Truly Adams, who is pursuing a pathway to Formula 1. The partnership will include national marketing campaigns, event appearances, and digital content series throughout 2026, featuring behind-the-scenes training, competition coverage, and storytelling from the road.<\/p>\n

\nAs Petersen pushes toward a world title in 2026, OSRX will support his journey\u2014reinforcing a shared belief at the core of the campaign: success is earned, not given.<\/p>\n

\nLearn more about OSRX and follow Petersen\u2019s 2026 season through the Ride with OSRX campaign at ridewithosrx.com<\/a>.<\/p>\n

\nAbout OSRX<\/b><\/p>\n

\nOSRX is an FDA-registered 503B outsourcing facility dedicated to advancing ophthalmic care through high-quality compounded solutions that simplify treatment for prescribers and patients. Operating nationwide, the Montana-based company is trusted by more than 10,000 prescribers and is driven by its vision to deliver high-quality medications at affordable prices. Learn more at www.osrxpharmaceuticals.com<\/a>.<\/p>\n

\nOSRX glaucoma and other compounded medications carry serious risks, including elevation of intraocular pressure, conjunctivitis, and decreased visual acuity. View potential adverse events and contraindications at: https:\/\/osrxpharmaceuticals.com\/osrx-api-aecontraindication<\/a>. For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Vanessa Assam-Gorski, Director of Marketing<\/b>
vmgorski@osrxphamaceuticals.com<\/b><\/a> or 541-944-8531<\/b><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MISSOULA, Mont.–(BUSINESS WIRE)–#BarebackRiding–OSRX, Inc., an FDA-registered outsourcing facility specializing in compounded ophthalmic medications, today announced a partnership with professional rodeo athlete and Montana native Sam Petersen\u2014the 2025 world No. 2 bareback rider and Wrangler National Finals Rodeo average champion. The collaboration advances the company\u2019s Ride with OSRX campaign\u2014an initiative celebrating rising American talent forged through … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62975","6":"format-standard","7":"category-industry"},"yoast_head":"\nOSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MISSOULA, Mont.–(BUSINESS WIRE)–#BarebackRiding–OSRX, Inc., an FDA-registered outsourcing facility specializing in compounded ophthalmic medications, today announced a partnership with professional rodeo athlete and Montana native Sam Petersen\u2014the 2025 world No. 2 bareback rider and Wrangler National Finals Rodeo average champion. The collaboration advances the company\u2019s Ride with OSRX campaign\u2014an initiative celebrating rising American talent forged through ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T02:02:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season\",\"datePublished\":\"2026-04-21T02:02:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/\"},\"wordCount\":630,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260420902919\\\/en\\\/2780113\\\/22\\\/Sam_v2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/\",\"name\":\"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260420902919\\\/en\\\/2780113\\\/22\\\/Sam_v2.jpg\",\"datePublished\":\"2026-04-21T02:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260420902919\\\/en\\\/2780113\\\/22\\\/Sam_v2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260420902919\\\/en\\\/2780113\\\/22\\\/Sam_v2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/","og_locale":"en_US","og_type":"article","og_title":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend","og_description":"MISSOULA, Mont.–(BUSINESS WIRE)–#BarebackRiding–OSRX, Inc., an FDA-registered outsourcing facility specializing in compounded ophthalmic medications, today announced a partnership with professional rodeo athlete and Montana native Sam Petersen\u2014the 2025 world No. 2 bareback rider and Wrangler National Finals Rodeo average champion. The collaboration advances the company\u2019s Ride with OSRX campaign\u2014an initiative celebrating rising American talent forged through ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-21T02:02:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season","datePublished":"2026-04-21T02:02:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/"},"wordCount":630,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/","url":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/","name":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg","datePublished":"2026-04-21T02:02:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260420902919\/en\/2780113\/22\/Sam_v2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/osrx-teams-up-with-pro-rodeo-standout-sam-petersen-following-breakout-2025-season\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62975"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62975\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}